A Bayesian adaptive design for two-stage clinical trials with survival data

A randomized two-stage adaptive Bayesian design is proposed and studied for allocation and comparison in a phase III clinical trial with survival time as treatment response. Several exact and limiting properties of the design and the follow-up inference are studied, both numerically and theoretically, and are compared with a single-stage randomized procedure. The applicability of the proposed methodology is illustrated by using some real data.

[1]  R. Prentice.  A LOG GAMMA MODEL AND ITS MAXIMUM LIKELIHOOD ESTIMATION , 1974 .

[2]  Atanu Biswas,et al.  Bayesian Adaptive Biased‐Coin Designs for Clinical Trials with Normal Responses , 2005, Biometrics.

[3]  W F Rosenberger,et al.  Adaptive survival trials. , 1997, Journal of biopharmaceutical statistics.

[4]  Gwo Dong Lin,et al.  Maximum likelihood estimation of a survival function under the koziol-green proportional hazards model , 1987 .

[5]  Joseph L. Gastwirth,et al.  FISHER INFORMATION IN ORDERED RANDOMLY CENSORED DATA WITH APPLICATIONS TO CHARACTERIZATION PROBLEMS , 2003 .

[6]  H. Schäfer,et al.  Adaptive Group Sequential Designs for Clinical Trials: Combining the Advantages of Adaptive and of Classical Group Sequential Approaches , 2001, Biometrics.

[7]  Jean-Yves Dauxois,et al.  On testing the proportionality of two cumulative incidence functions in a competing risks setup , 2004 .

[8]  F. Hsieh.  Comparing sample size formulae for trials with unbalanced allocation using the logrank test. , 1992, Statistics in medicine.

[9]  D. S. Coad.  Some results on estimation for two—stage clinical trials , 1992 .

[10]  Jerald F. Lawless,et al.  Confidence Interval Estimation in the Inverse Power Law Model , 1976 .

[11]  J. Ware.  Investigating Therapies of Potentially Great Benefit: ECMO , 1989 .

[12]  P Bauer,et al.  Flexible Two-Stage Designs: An Overview , 2001, Methods of Information in Medicine.

[13]  R. Sposto,et al.  Use of unequal allocation in survival trials. , 1987, Statistics in medicine.

[14]  Peter F. Heil,et al.  Survival Distributions: Reliability Applications in the Biomedical Sciences , 1976 .

[15]  Uttam Bandyopadhyay,et al.  A covariate adjusted two‐stage allocation design for binary responses in randomized clinical trials , 2007, Statistics in medicine.

[16]  J. Matthews,et al.  Randomization in Clinical Trials: Theory and Practice; , 2003 .

[17]  M. Hollander,et al.  Small-Sample Results for the Kaplan-Meier Estimator , 1982 .

[18]  Lee-Jen Wei,et al.  Play the winner for phase II/III clinical trials. , 1996, Statistics in medicine.

[19]  Ursula Gather,et al.  Estimating the survival function under a generalized Koziol-Green model with partially informative censoring , 1998 .

[20]  Irène Gijbels,et al.  Quantile estimation in the proportional hazards model of random censorship , 1989 .

[21]  N. Veraverbeke,et al.  The partial Koziol-Green model with covariates , 2001 .

[22]  J. Klein,et al.  Statistical Models Based On Counting Process , 1994 .

[23]  D G Altman,et al.  The hidden effect of time. , 1988, Statistics in medicine.

[24]  Thomas A. Louis,et al.  Sequential treatment allocation in clinical trials , 1971 .

[25]  Winfried Stute.  Strong consistency under the Koziol—Green model , 1992 .

[26]  Douglas E. Faries,et al.  A Case Study of an Adaptive Clinical Trial in the Treatment of Out-Patients with Depressive Disorder , 1994 .

[27]  Carmen Cadarso-Suárez,et al.  Estimation of the conditional distribution in a conditional Koziol-green model , 2000 .

[28]  M A Proschan,et al.  Designed extension of studies based on conditional power. , 1995, Biometrics.

[29]  Nader Ebrahimi,et al.  Nonparametric estimation of survival functions for incomplete observations when the life time distribution is proportionally related ot the censoring time distribution , 1985 .

[30]  John Lawrence,et al.  STRATEGIES FOR CHANGING THE TEST STATISTIC DURING A CLINICAL TRIAL , 2002, Journal of biopharmaceutical statistics.

[31]  A Hallstrom,et al.  Logrank, play the winner, power and ethics. , 1996, Statistics in medicine.

[32]  Anthony C. Atkinson,et al.  Optimum Experimental Designs , 1992 .

[33]  A. Atkinson.  Optimum biased coin designs for sequential clinical trials with prognostic factors , 1982 .

[34]  Grzegorz Opolski,et al.  Evaluation of the Safety and Cardioprotective Effects of Eniporide, a Specific Sodium/Hydrogen Exchange Inhibitor, Given as Adjunctive Therapy to Reperfusion in Patients with Acute Myocardial Infarction , 2001, Heart Drug.

[35]  P. Sen,et al.  Theory of rank tests , 1969 .

[36]  Emil Frei,et al.  The Effect of 6-Mercaptopurine on the Duration of Steroid-induced Remissions in Acute Leukemia: A Model for Evaluation of Other Potentially Useful Therapy , 1963 .

[37]  L. J. Wei,et al.  The Randomized Play-the-Winner Rule in Medical Trials , 1978 .

[38]  J. N. S. Matthews,et al.  An introduction to randomized controlled clinical trials , 2000 .

[39]  Peter F Thall,et al.  Monitoring the Rates of Composite Events with Censored Data in Phase II Clinical Trials , 2002, Biometrics.

[40]  Lajos Horváth,et al.  On the Koziol-Green model for random censorship , 1981 .

[41]  James A. Koziol,et al.  A Cramér-von Mises statistic for randomly censored data , 1976 .

[42]  Isabella Verdinelli,et al.  Biased coin designs with a Bayesian bias , 1993 .

[43]  Shein-Chung Chow.  Encyclopedia of Biopharmaceutical Statistics , 2010 .

[44]  S. D. Durham,et al.  A sequential design for maximizing the probability of a favourable response , 1998 .

[45]  C. Rout,et al.  A Reevaluation of the Role of Crystalloid Preload in the Prevention of Hypotension Associated with Spinal Anesthesia for Elective Cesarean Section , 1993, Anesthesiology.

[46]  Pawlitschko Jörg.  A Comparison of Survival Function Estimators in the Koziol–Green Model , 1999 .

[47]  Peter Bauer,et al.  A simulation program for adaptive two stage designs , 1998 .

[48]  Wenceslao González-Manteiga,et al.  Distributional convergence under proportional censorship when covariables are present , 1998 .

[49]  G. Chi,et al.  On Sample Size and Inference for Two‐Stage Adaptive Designs , 2001, Biometrics.

[50]  Marvin Zelen,et al.  Factorial Experiments in Life Testing , 1959 .

[51]  Joseph L. Gastwirth,et al.  On the Fisher information in randomly censored data , 2001 .

[52]  M Zelen,et al.  Estimation of exponential survival probabilities with concomitant information. , 1965, Biometrics.

[53]  R. G. Cornell,et al.  Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study. , 1985, Pediatrics.

[54]  D. S. Coad.  Sequential estimation for two-stage and three-stage clinical trials , 1994 .

[55]  M. Zelen,et al.  Play the Winner Rule and the Controlled Clinical Trial , 1969 .

[56]  P. Bauer,et al.  Adaptive Two Stage Designs and the Conditional Error Function , 1999 .

[57]  M. Buyse,et al.  Cancer Clinical Trials: Methods and Practice. , 1985 .

[58]  Wenceslao González-Manteiga,et al.  Strong consistency under proportional censorship when covariables are present , 1999 .

[59]  Chen-Hsin Chen.  A correlation goodness-of-fit test for randomly censored data , 1984 .

[60]  R. L. Prentice,et al.  Exponential survivals with censoring and explanatory variables , 1973 .

[61]  Norbert Henze,et al.  A quick omnibus test for the proportional hazards model of random censorship , 1993 .

[62]  J. Ghorai,et al.  Estimation of a smooth quantile function under the proportional hazards model , 1991 .

[63]  A. Biswas,et al.  A RANDOMIZED LONGITUDINAL PLAY‐THE‐WINNER DESIGN FOR REPEATED BINARY DATA , 2004 .

[64]  M. Hollander,et al.  Testing to Determine the Underlying Distribution Using Randomly Censored Data. , 1979 .

[65]  D. Cox,et al.  THE ANALYSIS OF EXPONENTIALLY DISTRIBUTED LIFE-TIMES WITH Two TYPES OF FAILURE , 1959 .

[66]  Michael A. Proschan,et al.  A Unified Theory of Two-Stage Adaptive Designs , 2002 .

[67]  N. Cook,et al.  The Effects of Nonpharmacologic Interventions on Blood Pressure of Persons With High Normal Levels: Results of the Trials of Hypertension Prevention, Phase I , 1992 .

[68]  Uttam Bandyopadhyay,et al.  Adaptive designs for normal responses with prognostic factors , 2001 .

[69]  Sundarraman Subramanian,et al.  Efficient estimation of regression coefficients and baseline hazard under proportionality of conditional hazards , 2000 .

[70]  H. Suryapranata,et al.  The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. , 2001, Journal of the American College of Cardiology.

[71]  Nader Ebrahimi,et al.  Testing to determine the underlying distribution using incomplete observations when the life time determine is proportionally related to the censoring time distribution , 1992 .

[72]  Michael A Proschan,et al.  Practical midcourse sample size modification in clinical trials. , 2003, Controlled clinical trials.

[73]  Anastasia Ivanova,et al.  A play-the-winner-type urn design with reduced variability , 2003 .

[74]  Lanju Zhang,et al.  Response‐adaptive randomization for survival trials: the parametric approach , 2007 .